Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $83.13M in the quarter ending March 31, 2026, with 38.27% growth. This brings the company's revenue in the last twelve months to $314.85M, up 41.47% year-over-year. In the year 2025, Xeris Biopharma Holdings had annual revenue of $291.85M with 43.72% growth.

• Revenue (ttm): $314.85M
• Revenue Growth: +41.47%
• P/S Ratio: 4.22
• Revenue / Employee: $723,800
• Employees: 435
• Market Cap: 1.33B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	291.85M	88.78M	43.72%
Dec 31, 2024	203.07M	39.16M	23.89%
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%
Dec 31, 2019	2.72M	299.00K	12.34%
Dec 31, 2018	2.42M	867.00K	55.72%
Dec 31, 2017	1.56M	481.00K	44.74%
Dec 31, 2016	1.08M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error